2021
DOI: 10.1097/ju.0000000000001751
|View full text |Cite
|
Sign up to set email alerts
|

Contemporary Trends and End-Results of National Institutes of Health Grant Funding to Departments of Urology in the United States: A 10-year Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
(26 reference statements)
0
1
0
Order By: Relevance
“…As a report by Hakam et al (page 427) from San Francisco, California and Baltimore, Maryland shows, though, the field still lags behind compared with other subspecialties, including within surgical disciplines. 9 Over the time period of 2010e2019, National Institutes of Health grants to urology departments decreased in total funding by 15.6%. Over half of the grants went to a principal investigator (PI) with a urologic oncology specialty; 21.6% of all grants had a female PI and they were more likely to be a PhD basic scientist than males (64% vs 38%).…”
Section: Study Of Ketorolac Vs Opioid For Pain After Endoscopymentioning
confidence: 99%
“…As a report by Hakam et al (page 427) from San Francisco, California and Baltimore, Maryland shows, though, the field still lags behind compared with other subspecialties, including within surgical disciplines. 9 Over the time period of 2010e2019, National Institutes of Health grants to urology departments decreased in total funding by 15.6%. Over half of the grants went to a principal investigator (PI) with a urologic oncology specialty; 21.6% of all grants had a female PI and they were more likely to be a PhD basic scientist than males (64% vs 38%).…”
Section: Study Of Ketorolac Vs Opioid For Pain After Endoscopymentioning
confidence: 99%
“…While only 1% of National Institutes of Health grant funding of urologic research is awarded to male reconstruction and trauma, efforts in the reconstructive community, including the founding of the Society of Genitourinary Reconstructive Surgeons Multi-Institutional Trials Committee, seek to increase high-quality, and potentially fundable, research. 2 This manuscript offers a blueprint for others to follow in that endeavor. Just as we have seen remarkable advances in targeted therapies within urologic oncology, via the study of cellular signaling pathways and genetics, efforts to better understand the pathophysiology of benign conditions like stricture disease will allow for an expansion of our reconstructive armamentarium.…”
mentioning
confidence: 99%